Arcus Biosciences, Inc.
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 cl…
Biotechnology
US, Hayward [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Arcus Biosciences, Inc. has no acquisition track records yet.
M&A Deals · History
Arcus Biosciences, Inc. has no acquisition track records yet.